[EN] 5-O-SUBSTITUTED 3-N-PHENYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE<br/>[FR] 3-N-PHÉNYL-1,3,4-OXADIAZOLONES 5-O-SUBSTITUÉES POUR UNE UTILISATION MÉDICALE
申请人:BIAL PORTELA & COMPANHIA S A
公开号:WO2009084970A1
公开(公告)日:2009-07-09
The present invention relates to compounds having a 5-O-substituted 3-N-phenyl-1,3,4-oxadiazolone structural unit which have unexpectedly high level of inhibition of FAAH (fatty acid amide hydrolase). (I)
PIRKLE W. H.; GRAVEL P. L., J. ORG. CHEM. <JOCE-AH>, 1976, 41, NO 23, 3763-3765
作者:PIRKLE W. H.、 GRAVEL P. L.
DOI:——
日期:——
Oxidation catalyst
申请人:Suzuki Ken
公开号:US20060229471A1
公开(公告)日:2006-10-12
An oxidation catalyst for use in the oxidation of a substrate with a molecular oxygen, comprising at least one member selected from the group consisting of a specific hydrazyl radical (such as 2,2-diphenyl-1-picrylhydrazyl) and a specific hydrazine compound (such as 2,2-diphenyl-1-picrylhydrazine). A method for producing a chemical compound, comprising contacting a substrate with a molecular oxygen in the presence of the above-mentioned oxidation catalyst.